一品红参股企业畅溪制药与以岭药业达成战略合作 共同开发创新型吸入药物

Core Viewpoint - The strategic collaboration between Hangzhou Changxi Pharmaceutical Co., Ltd. and Shijiazhuang Yiling Pharmaceutical Co., Ltd. focuses on the development of innovative drugs for lung and related diseases, leveraging Changxi's expertise in inhalation powder technology [1] Company Summary - Hangzhou Changxi Pharmaceutical Co., Ltd. is a subsidiary of Yipinhong and specializes in the development of inhalation powder formulations [1] - Shijiazhuang Yiling Pharmaceutical Co., Ltd. is engaged in the research and development of innovative drug molecules targeting lung diseases [1] Industry Summary - The collaboration aims to combine the strengths of both companies to ensure the market success of the developed products in the therapeutic area of lung diseases [1]